The long-term effect of continuous subcutaneous apomorphine infusions on camptocormia in Parkinson's disease

Parkinsonism Relat Disord. 2020 Jun:75:14-16. doi: 10.1016/j.parkreldis.2020.05.015. Epub 2020 May 12.

Authors

Kateřina Menšíková¹, Michaela Kaiserová², Miroslav Vaštík², Martin Nevrlý², Sandra Kurčová², Petr Kaňovský², Carlo Colosimo³

Affiliations

¹ Department of Neurology, Palacký University Medical School and University Hospital, Olomouc, Czech Republic. Electronic address: katmen@centrum.cz.
² Department of Neurology, Palacký University Medical School and University Hospital, Olomouc, Czech Republic.
³ Department of Neurology, Santa Maria University Hospital, Terni, Italy.

PMID: 32442812
DOI: 10.1016/j.parkreldis.2020.05.015

No abstract available

Keywords: Apomorphine infusion; Axial dystonia; Camptocormia; Parkinson's disease.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Apomorphine / administration & dosage
Apomorphine / pharmacology*
Dopamine Agonists / administration & dosage
Dopamine Agonists / pharmacology*
Female
Follow-Up Studies
Humans
Infusions, Subcutaneous
Male
Middle Aged
Muscular Atrophy, Spinal / drug therapy*
Muscular Atrophy, Spinal / etiology
Outcome Assessment, Health Care
Parkinson Disease / complications
Parkinson Disease / drug therapy*
Spinal Curvatures / drug therapy*
Spinal Curvatures / etiology

Substances

Dopamine Agonists
Apomorphine

Supplementary concepts

Camptocormia